Kingsview Wealth Management, LLC
Position in PRME — Prime Medicine, Inc.
CIK 1791965
GRANTS PASS, OR
Position in PRME
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$36,900
-$84,900 QoQ
Shares Held
10,000
-71.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#144
of 186 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PRME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kingsview Wealth Management, LLC holds $4,094,329 across 12 Biotechnology names. PRME ranks #11 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
25,674 | $1,001,542 | |
| 2 | IMRX |
Immuneering Corp
|
123,000 | $613,770 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,120 | $518,912 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
675 | $420,889 | |
| 5 | RPRX |
Royalty Pharma plc
|
6,377 | $357,558 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
15,895 | $296,441 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
464 | $230,482 | |
| 8 | INSM |
INSMED Inc
|
2,147 | $228,913 |
All Filings in PRME
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,900 | 10,000 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $121,800 | 35,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $52,050 | 15,000 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $137,115 | 24,750 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $61,750 | 25,000 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||